Association between Indoor Temperature in Winter and Serum Cholesterol: A Cross-Sectional Analysis of the Smart Wellness Housing Survey in Japan
Tóm tắt
Từ khóa
Tài liệu tham khảo
1) WHO: Prevention of cardiovascular disease: Guideline for assessment and management of cardiovascular risk. 2007 (accessed on Sep 13, 2021). Available from: http: //apps.who.int/iris/bitstream/handle/10665/43685/9789241547178_eng.pdf
2) WHO, World Heart Federation, and World Stroke Organization: Global atlas on cardiovascular disease prevention and control. 2011 (accessed on Sep 13, 2021). Available from: http: //apps.who.int/iris/handle/10665/44701
3) D’Agostino Sr. RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, and Kannel WB: General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation, 2008; 117: 743-753
4) Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, and Kannel WB: Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study. JAMA, 1986; 256: 2835-2838
5) Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, and Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation, 1998; 97: 1837-1847
6) Nishimura K, Okamura T, Watanabe M, Nakai M, Takegami M, Higashiyama A, Kokubo Y, Okayama A, and Miyamoto Y: Predicting Coronary Heart Disease Using Risk Factor Categories for a Japanese Urban Population, and Comparison with the Framingham Risk Score: The Suita Study. J Atheroscler Thromb, 2014; 21: 784-798
7) Nakai M, Watanabe M, Kokubo Y, Nishimura K, Higashiyama A, Takegami M, Nakao YM, Okamura T, and Miyamoto Y: Development of a Cardiovascular Disease Risk Prediction Model Using the Suita Study, a Population-Based Prospective Cohort Study in Japan. J Atheroscler Thromb, 2020; 27: 1160-1175
8) Satoh M, Ohkubo T, Asayama K, Murakami Y, Sugiyama D, Waki T, Tanaka-Mizuno S, Yamada M, Saitoh S, Sakata K, Irie F, Sairenchi T, Ishikawa S, Kiyama M, Okayama A, Miura K, Imai Y, Ueshima H, and Okamura T: A Combination of Blood Pressure and Total Cholesterol Increases the Lifetime Risk of Coronary Heart Disease Mortality: EPOCH–JAPAN. J Atheroscler Thromb, 2021; 28: 6-24
9) Zhang X, Patel A, Horibe H, Wu Z, Barzi F, Rodgers A, MacMahon S, and Woodward M: Asia Pacific Cohort Studies Collaboration. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol, 2003; 32: 563-572
10) Schwingshackl L, and Hoffmann G: Comparison of effects of long-term low-fat vs high-fat diets on blood lipid levels in overweight or obese patients: a systematic review and meta-analysis. J Acad Nutr Diet, 2013; 113: 1640-1661
11) Vafeiadou K, Weech M, Altowaijri H, Todd S, Yaqoob P, Jackson KG, and Lovegrove JA: Replacement of saturated with unsaturated fats had no impact on vascular function but beneficial effects on lipid biomarkers, E-selectin, and blood pressure: results from the randomized, controlled Dietary Intervention and VAScular function (DIVAS) study. Am J Clin Nutr, 2015; 102: 40-48
12) Wardlaw GM, and Snook JT: Effect of diets high in butter, corn oil, or high-oleic acid sunflower oil on serum lipids and apolipoproteins in men. Am J Clin Nutr, 1990; 51: 815-821
13) Rivellese AA, Auletta P, Marotta G, Saldalamacchia G, Giacco A, Mastrilli V, Vaccaro O, and Riccardi G: Long term metabolic effects of two dietary methods of treating hyperlipidaemia. BMJ, 1994; 308: 227-231
14) Mann S, Beedie C, and Jimenez A: Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med, 2014; 44: 211-221
15) Kodama S, Tanaka S, Saito K, Shu M, Sone Y, Onitake F, Suzuki E, Shimano H, Yamamoto S, Kondo K, Ohashi Y, Yamada N, and Sone H: Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med, 2007; 167: 999-1008
16) Craig WY, Palomaki GE, and Haddow JE: Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ, 1989; 298: 784-788
17) Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, and Reaven GM: Insulin resistance and cigarette smoking. Lancet, 1992; 339: 1128-1130
18) Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion (US), and Office on Smoking and Health (US): How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US), 2010
19) Leech JA, Nelson WC, Burnett RT, Aaron S, and Raizenne ME: It’s about time: a comparison of Canadian and American time-activity patterns. J Expo Anal Env Epid, 2002; 12: 427-432
20) Brasche S, and Bischof W: Daily time spent indoors in German homes–baseline data for the assessment of indoor exposure of German occupants. Int J Hyg Environ Health, 2005; 208: 247-253
21) Schweizer C, Edwards RD, Bayer-Oglesby L, Gauderman WJ, Ilacqua V, Juhani Jantunen M, Lai HK, Nieuwenhuijsen M, and Künzli N: Indoor time-microenvironment-activity patterns in seven regions of Europe. J Expo Sci Env Epid, 2007; 17: 170-181
22) WHO: Housing and health guidelines. 2018 (accessed on Sep 13, 2021). Available from: https: //www.who.int/publications/i/item/9789241550376
23) Ma X, Yan H, Zhang H, Wang M, Zhang Q, and Zhou X: Progress in the seasonal variations of blood lipids: A mini-review. Lipids Health Dis, 2020; 19: 108
24) Halonen JI, Zanobetti A, Sparrow D, Vokonas PS, and Schwartz J: Outdoor temperature is associated with serum HDL and LDL. Environ Res, 2011; 111: 281-287
25) Hong Y-C, Kim H, Oh S-Y, Lim Y-H, Kim S-Y, Yoon H-J, and Park M: Association of cold ambient temperature and cardiovascular markers. Sci Total Environ, 2012; 435-436: 74-79
26) Basu R, May Wu X, Malig BJ, Broadwin R, Gold EB, Qi L, Derby C, Jackson EA, and Green RS: Estimating the associations of apparent temperature and inflammatory, hemostatic, and lipid markers in a cohort of midlife women. Environ Res, 2017; 152: 322-327
27) Sartini C, Barry SJE, Whincup PH, Wannamethee SG, Lowe GDO, Jefferis BJ, Lennon L, Welsh P, Ford I, Sattar N, and Morris RW: Relationship between outdoor temperature and cardiovascular disease risk factors in older people. Eur J Prev Cardiol, 2017; 24: 349-356
28) Housing Bureau, Ministry of Land, Infrastructure, Transport and Tourism: The first session of the committee on energy saving measures for houses and buildings for a decarbonized society (in Japanese). 2021 (accessed on Dec 9, 2021). Available from: https://www.mlit.go.jp/jutakukentiku/house/content/001400905.pdf
29) Umishio W, Ikaga T, Fujino Y, Ando S, Kubo T, Nakajima Y, Hoshi T, Suzuki M, Kario K, Yoshimura T, Yoshino H, and Murakami S: Disparities of indoor temperature in winter: A cross-sectional analysis of the Nationwide Smart Wellness Housing Survey in Japan. Indoor Air, 2020; 30: 1317-1328
30) Umishio W, Ikaga T, Kario K, Fujino Y, Hoshi T, Ando S, Suzuki M, Yoshimura T, Yoshino H, and Murakami S: Cross-sectional Analysis of the Relationship between Home Blood Pressure and Indoor Temperature in Winter: A Nationwide Smart Wellness Housing Survey in Japan. Hypertension, 2019; 74: 756-766
31) Friedewald WT, Levy RI, and Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
32) Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S, and Committee for Epidemiology and Clinical Management of Atherosclerosis: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb, 2018; 25: 846-984
33) Kitamura A, Noda H, Nakamura M, Kiyama M, Okada T, Imano H, Ohira T, Sato S, Yamagishi K, and Iso H: Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese: the Circulatory Risk in Communities Study (CIRCS). J Atheroscler Thromb, 2011; 18: 454-463
34) Puri R, Nissen SE, Shao M, Elshazly MB, Kataoka Y, Kapadia SR, Tuzcu EM, and Nicholls SJ: Non-HDL cholesterol and triglycerides: Implications for coronary atheroma progression and clinical events. Arterioscl Throm Vas, 2016; 36: 2220-2228
35) Brunner FJ, Waldeyer C, Ojeda F, Salomaa V, Kee F, Sans S, Thorand B, Giampaoli S, Brambilla P, Tunstall-Pedoe H, Moitry M, Iacoviello L, Veronesi G, Grassi G, Mathiesen EB, Söderberg S, Linneberg A, Brenner H, Amouyel P, Ferrières J, Tamosiunas A, Nikitin YP, Drygas W, Melander O, Jöckel K-, Leistner DM, Shaw JE, Panagiotakos DB, Simons LA, Kavousi M, Vasan RS, Dullaart RPF, Wannamethee SG, Risérus U, Shea S, de Lemos JA, Omland T, Kuulasmaa K, Landmesser U, Blankenberg S, Zeller T, Kontto J, Männistö S, Metspalu A, Lackner K, Wild P, Peters A, Meisinger C, Donfrancesco C, Signorini SG, Alver M, Woodward M, Gianfagna F, Costanzo S, Wilsgaard T, Eliasson M, Jørgensen T, Völzke H, Dörr M, Nauck M, Schöttker B, Lorenz T, Makarova N, Twerenbold R, Dallongeville J, Dobson A, Malyutina S, Pajak A, Engström G, Bobak M, Schmidt B, Jääskeläinen T, Niiranen T, Jousilahti P, Giles G, Hodge A, Klotsche J, Magliano DJ, Lyngbakken MN, Hveem K, Pitsavos C, Benjamin EJ, Bakker SJL, Whincup P, Ikram MK, Ingelsson M, and Koenig W: Application of non-HDL cholesterol for population-based cardiovascular risk stratification: Results from the multinational cardiovascular risk consortium. Lancet, 2019; 394: 2173-2183
36) Suzuki K, Oikawa T, Nochioka K, Miura M, Kasahara S, Sato M, Aoyanagi H, Shiroto T, Takahashi J, Miyata S, Sakata Y, and Shimokawa H: Elevated serum non-HDL (high-density lipoprotein) cholesterol and triglyceride levels as residual risks for myocardial infarction recurrence under statin treatment. Arterioscl Throm Vas, 2019; 39: 934-944
37) Saito I, Yamagishi K, Kokubo Y, Yatsuya H, Iso H, Sawada N, Inoue M, and Tsugane S: Non-High-Density Lipoprotein Cholesterol and Risk of Stroke Subtypes and Coronary Heart Disease: The Japan Public Health Center-Based Prospective (JPHC) Study. J Atheroscler Thromb, 2020; 27: 363-374
38) Yasutake K, Miyoshi E, Kajiyama T, Umeki Y, Misumi Y, Horita N, Murata Y, Ohe K, Enjoji M, and Tsuchihashi T: Comparison of a salt check sheet with 24-h urinary salt excretion measurement in local residents. Hypertens Res, 2016; 39: 879-885
39) Department of Health, UK. 2009 Annual Report of the Chief Medical Officer. 2010 (accessed on Sep 13, 2021). Available from: http: //www.sthc.co.uk/Documents/CMO_Report_2009.pdf.
40) Hata Y, Mabuchi H, Saito Y, Itakura H, Egusa G, Ito H, Teramoto T, Tsushima M, Tada N, Oikawa S, Yamada N, Yamashita S, Sakuma N, and Sasaki J: Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults. J Atheroscler Thromb, 2002; 9: 1-27
41) Robinson D, Bevan EA, Hinohara S, and Takahashi T: Seasonal variation in serum cholesterol levels - evidence from the UK and Japan. Atherosclerosis, 1992; 95: 15-24
42) Ockene IS, Chiriboga DE, Stanek III EJ, Harmatz MG, Nicolosi R, Saperia G, Well AD, Freedson P, Merriam PA, Reed G, Ma Y, Matthews CE, and Hebert JR: Seasonal variation in serum cholesterol levels: Treatment implications and possible mechanisms. Arch Intern Med, 2004; 164: 863-870
43) Rosmond R, Björntorp P: The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med, 2000; 247: 188-197
44) JCS, JSH and JCC Joint Working Group: Guidelines for Disaster Medicine for Patients With Cardiovascular Diseases (JCS 2014/JSH 2014/JCC 2014) - Digest Version. Circ J, 2016; 80: 261-284
45) Chrousos GP, Gold PW: A healthy body in a healthy mind--and vice versa--the damaging power of “uncontrollable” stress. J Clin Endocr Metab, 1998; 83: 1842-1845
46) Rosmond R, Dallman MF, Björntorp P: Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocr Metab, 1998; 83: 1853-1859
47) Shiue I: Cold homes are associated with poor biomarkers and less blood pressure check-up: English longitudinal study of ageing, 2012–2013. Environ Sci Pollut Res, 2016; 23: 7055-7059
48) Martin M, Browner WS, Hulley SB, Kuller LH, and Wentworth D: Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361,662 men. Lancet, 1986; 328: 933-936
49) Pekkanen J, Linn S, Heiss G, Suchindran CM, Leon A, Rifkind BM, and Tyroler HA: Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med, 1990; 322: 1700-1707
50) Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet, 1994; 344: 1383-1389
51) Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, Mckillop JH, and Packard CJ: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med, 1995; 333: 1301-1308
52) Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, and Wilson PWF: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation, 2014; 129: S1-S45
53) Landmesser U, Chapman MJ, Stock JK, Amarenco P, Belch JJF, Borén J, Farnier M, Ference BA, Gielen S, Graham I, Grobbee DE, Hovingh GK, Lüscher TF, Piepoli MF, Ray KK, Stroes ES, Wiklund O, Windecker S, Zamorano JL, Pinto F, Tokgözoğlu L, Bax JJ, and Catapano AL: 2017 update of ESC/EAS task force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. Eur Heart J, 2018; 39: 1131-1143
54) Hooper L, Bartlett C, Smith GD, and Ebrahim S: Systematic review of long term effects of advice to reduce dietary salt in adults. Br Med J, 2002; 325: 628-632
55) Pennant M, Davenport C, Bayliss S, Greenheld W, Marshall T, and Hyde C: Community programs for the prevention of cardiovascular disease: A systematic review. Am J Epidemiol, 2010; 172: 501-516